MHRA Drug Safety Update May 2022
Links to the MHRA Drug Safety Update for May 2022 are listed below.
- Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia
- COVID-19 vaccines and medicines: updates for May 2022
- Letters and medicine recalls sent to healthcare professionals in April 2022
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published: 23/05/2022. Medicines Update blogs are correct at the time of publishing.
We would like to hear what you think of Medicines Update blogs. Please leave us your feedback using this anonymous survey here.